SpyGlass Pharma (SGP) news
Recent news
Spyglass Pharma, - buys AVS for about $13 mln in cash
Spyglass Pharma has announced the acquisition of AVS for approximately $13 million in cash, marking a strategic move to expand its portfolio and capabilities in the pharmaceutical sector. The transaction, which is expected to close in the coming weeks, underscores Spyglass Pharma’s commitment to…
AInvest Wire · Oct 1, 2026Insilico: Contract value up to 'tenes of millions of US dollars'
Insilico Medicine (HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has reported significant business development (BD) activity in 2026, with total contract value from collaborations reaching up to tens of millions of US dollars. These…
AInvest Wire · Sep 21, 2026Spyglass Pharma appoints Mike Pinder as vice president, marketing
AInvest Wire · Jun 2, 2026ImportantGalp to launch EUR 250m share buyback of Galp Energia SGPS
AInvest Wire · Mar 2, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.